In the framework of the ACH2.0, elicitation of the ISR in human neuronal cells by means other than AβPP-derived iAβ would be sufficient to activate the endogenous AβPP-independent iAβ production pathway and to trigger the progression of the AD pathology. This evidence concerns the gene APP and Alzheimer disease.